The Pharma Data

MAY 14, 2021

I have a cure for hives and angioedema! It is a natural cure which means it cannot be registered as a patent thus it cannot be marketed using the regular channels (drug industry-pharmacies etc.). Let’s see a pharmacy or doctor top that! Let’s see a pharmacy or doctor top that! Let’s see a pharmacy or doctor top that!

Treatment 52

Treatment Doctors Pharmacy Production 52

Drug Patent Watch

JANUARY 7, 2025

It’s always a good idea to compare prices at different pharmacies. ” Health Affairs, 2011. FAQs Q: Are generic drugs always cheaper than brand-name medications? A: While generic drugs are typically much less expensive than brand-name medications, prices can vary. A: In most cases, yes. ” WHO.int, 2020. Shrank, W.H.,

Drugs 89

Drugs FDA Doctors Trials 89

Drug & Device Law

DECEMBER 29, 2023

Since the FDA requires pre-approval of any warnings about off-label uses, preemption at some point should have been pre-ordained under the Mensing ( 2011+1 ) independence principle, but off-label use did not really figure in Zofran ’s analysis. OTC drugs also have an express preemption provision, but it contains an exception for Prop 65.

Testimonials 105

Testimonials Drugs FDA Vaccine 105

Drug & Device Law

NOVEMBER 2, 2023

A court within the Fifth Circuit has held that the FDCA impliedly preempts unfair-competition and consumer-protection claims asserted by a drug manufacturer against a compounding pharmacy. There is, however, an exception for drugs produced by a qualifying compounding pharmacy. Pharmacy v. 2011)—reads Buckman Co.

Compounding Pharmacies 59

Compounding Pharmacies Pharmacy FDA Approval FDA 59

Drug & Device Law

JULY 24, 2023

Nonetheless, the Ninth Circuit’s PATDC82 I allowed a RICO claim alleging that, between 1999 and 2011, defendants concealed that risk from the FDA and that, as a result, every TPP in the country paid for Actos prescriptions that it otherwise would not have reimbursed. the relationship between [plaintiff] and its pharmacy benefit manager. . .

Testimonials 52

Testimonials Pharmacy FDA Doctors 52

Drug & Device Law

MAY 26, 2023

2011), aff’d , 741 F.3d They can regulate doctors, pharmacies, and grocery stores, but cannot ban an FDA-approved drug like they can pork that comes from pigs not raised in a specific way, the gist of the California law at issue in NPP. See Gross v. Pfizer, Inc. , 2d 654, 659 (D. 3d 470 (4th Cir.

Regulations 59

Regulations Production FDA FDA Approval 59

Drug & Device Law

MAY 19, 2023

In 2011 (during the Obama Administration), the FDA completed the REMS for mifepristone, mandating that it “only be prescribed by certified physicians, dispensed in certain healthcare facilities, and taken in the provider’s clinic.” Sorsaia , 2023 WL 3211847, at *2. Its] FDA approval allows it to sell mifepristone nationwide. . . . [T]he

FDA Approval 111

FDA Approval Pharmacy FDA Production 111

Drug & Device Law

MARCH 31, 2023

Criticizing attempts to sue publishers of scientific content, here in 2011, and again, here in 2013. at *2 (citing, inter alia , Virginia State Board of Pharmacy v. Supporting scientific articles as First Amendment-supported speech, here in 2009. Celebrating scientific free speech, here , on the Fourth of July in 2013.

Production 59

Production Pharmacy Doctors Government 59

Drug & Device Law

MARCH 30, 2023

552 (2011), and especially in the months after the Supreme Court revisited the subject of content-based speech restrictions more generally in City of Austin v. IMS Health, Inc. , Reagan Nat’l Adver. of Austin , 142 S.

Vaccine 75

Vaccine Pharmacy FDA Treatment 75

Drug & Device Law

FEBRUARY 20, 2023

223, 238 (2011), the United States Supreme Court reacted to a plaintiff’s unconstrained claims of “alternative” vaccine design: [T]he [design] decision is surely not an easy one. In at least the short term, a popular pain reliever would have to be removed from pharmacies. In Bruesewitz v. Wyeth LLC , 562 U.S. at 164 (quoting Wolfe v.

FDA 59

FDA FDA Approval Testimonials Vaccine 59

Drug & Device Law

JANUARY 27, 2022

The plaintiff brought five claims against the drug’s manufacturer and three against the pharmacy that dispensed the drug. The plaintiff’s claims against the dispensing pharmacy fared no better. Applying PLIVA, Inc. Mensing, 564 U.S. 2022 WL 204401, at *7–10. Bartlett, 570 U.S. 2022 WL 204401, at *11. 2022 WL 204401, at *12–14.

Pharmacy 72

Pharmacy Drugs Pharmaceuticals 72